Detection of hepatitis B precore mutants by the fluorescent linear polymerase chain reaction sequencing method

J Hepatol. 1994 Dec;21(6):934-9. doi: 10.1016/s0168-8278(05)80598-7.

Abstract

To evaluate the presence of precore mutants, serum samples from 25 patients with chronic hepatitis B, HBV-DNA positive (5 HBeAg and 20 anti-HBe positive) were studied. The complete precore-core region of HBV-DNA was directly sequenced after polymerase chain reaction amplification by a fluorescent linear polymerase chain reaction sequencing method. Precore variants were detected in one HBeAg positive and in all 20 anti-HBe positive patients: in 19 cases, G to A at position 1896, with or without the substitution G to A at position 1899, in two cases C to T substitution at position 1817 which also produces a stop codon (CAA to TAA), one accompanied by the mutation G to A at position 1896. The only mutation observed in the patient who was initially HBeAg positive patient was a G to A substitution at position 1899. Consecutive serum samples from a patient with chronic hepatitis B, initially had the simultaneous presence of wild type and variant strains. Elimination of the wild-type strain was associated with reactivation of liver disease. Analysis of the sequences obtained demonstrated the heterogeneity of the hepatitis B virus genome in the precore-core region. These results indicate that the main cause of non-expression of HBeAg in chronic hepatitis B in our country is the substitution of G to A at nucleotide 1896, alone or accompanied by other variants. Fluorescent linear polymerase chain reaction is a fast and sensitive method to study heterogeneity in the precore-core region.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • DNA, Viral / analysis
  • Hepatitis Antibodies / analysis
  • Hepatitis B / genetics*
  • Hepatitis B Core Antigens / genetics*
  • Hepatitis B e Antigens / analysis
  • Hepatitis B e Antigens / immunology
  • Humans
  • Molecular Sequence Data
  • Mutation*
  • Oligonucleotide Probes / genetics
  • Polymerase Chain Reaction / methods*

Substances

  • DNA, Viral
  • Hepatitis Antibodies
  • Hepatitis B Core Antigens
  • Hepatitis B e Antigens
  • Oligonucleotide Probes